Diadem Biotherapeutics
PrivateLast Round
Grant
Sep 1, 2026
Total Funding Raised
$4.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Diadem Biotherapeutics operates in Healthcare & Life Sciences and is based in Torrance, California. Its latest recorded funding round was a Grant round in September 2026.
Diadem Biotherapeutics is a biotechnology company that develops engineered extracellular vesicle-based immunotherapies to treat cancer, chronic inflammatory, and autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diadem Biotherapeutics Comparables
Compare Diadem Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EV Therapeutics | 86% | |
| Ciloa | 81% | |
| SHIFTBIO | 79% |
For institutional investors. Book with your work email.
Diadem Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2026 | ||||
| Seed | Jul 1, 2021 |
For institutional investors. Book with your work email.
Diadem Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novateur Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Secured $4M in grant funding.
- Jul 29, 2026
Monthly visitors increased 65% MoM.
For institutional investors. Book with your work email.
Diadem Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Diadem Biotherapeutics's valuation, stock price, and market status.
Is Diadem Biotherapeutics a public or private company?
Diadem Biotherapeutics is a private company.
What is the current stock price of Diadem Biotherapeutics?
Diadem Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Diadem Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Diadem Biotherapeutics worth (valuation)?
Valuation information for Diadem Biotherapeutics is not publicly available.
Can I buy Diadem Biotherapeutics stock?
Diadem Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Diadem Biotherapeutics's last funding round?
Diadem Biotherapeutics's most recent funding round was Grant on September 1, 2026.
Who are the main investors in Diadem Biotherapeutics?
Key investors in Diadem Biotherapeutics include Novateur Ventures.
Will Diadem Biotherapeutics IPO soon?
No public IPO plans have been announced for Diadem Biotherapeutics.
How can I track Diadem Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Diadem Biotherapeutics's shares on secondary markets.